aTyr Pharma (NASDAQ:LIFE) reported quarterly losses of $(0.46) per share which met the analyst consensus estimate. This is a 9.52 percent decrease over losses of $(0.42) per share from the same period last year.
HF Sinclair Corporation and Holly Energy Partners Announce Management Changes
HF Sinclair Corporation (NYSE:DINO) ("HF Sinclair") today announced the appointment of Atanas H. Atanasov as Executive Vice President and Chief Financial Officer of HF Sinclair effective September 30, 2022, and